Five NRGs were identified to have a significant correlation with the prognosis of BLCA patients: CAMK2A, CHMP4C, IL33, IRF9, and TRAF5 (Supplementary Table S5; Figure 6). This evidence concerns the gene TRAF5 and bladder transitional cell carcinoma.